12:32 : NPS Pharmaceuticals ([[NPSP]] +5.4%) clocks a gain a day after announcing -
NPS Pharmaceuticals (NPSP +5.4%) clocks a gain a day after announcing it completed its submission to the FDA for its experimental Gattex drug - a hopeful sign which follows the firm reporting "adverse events" in October with ...
13:45 : NPS Pharmaceuticals ([[NPSP]] -3.7%) gives back all its premarket gains ... -
NPS Pharmaceuticals (NPSP -3.7%) gives back all its premarket gains and more, despite the company's postive Phase 3 results for its hypoparathyroid treatment earlier today. The company has been on a steady downtrend, losing ...
12:09 : NPS Pharmaceuticals plunges on drug study -
BOSTON (MarketWatch) -- Shares of NPS Pharmaceuticals plunged 33% to $5.20 Monday after it reported mixed Phase III clinical data for its gastrointestinal treatment Gattex in the treatment of a rare condition ...
18:07 : NPS Pharmaceuticals (NPSP) terminates and replaces a prior collaborative ... -
NPS Pharmaceuticals (NPSP) terminates and replaces a prior collaborative research agreement with GlaxoSmithKline (GSK) dating back to 1993. The new agreement will assign two new compounds for study and expand the company's field ...